Life Extension Spring Clearance Sale

Pain (Chronic) References

Disease Prevention and Treatment, 5th edition

The references on this page correspond with the print version of Disease Prevention and Treatment, 5th edition. Since we continuously update the protocols online in response to new scientific developments, readers are encouraged to review the latest versions of the protocols.

  1. MedlinePlus. Pain. Available at: http://www.nlm.nih.gov/medlineplus/pain.html. Updated 4/27/2012. Accessed 5/2/2012.
  2. Cleveland Clinic. Acute vs. Chronic Pain. Treatments & Procedures page. Available at: http://my.clevelandclinic.org/services/pain_management/hic_acute_vs_chronic_pain. aspx. Last updated 9/12/2008. Accessed 7/11/2013.
  3. MedicineNet.com Chronic Pain. Available at: http://www.medicinenet.com/chronic_pain/article.htm Accessed 4/19/2012.
  4. Vo, P, Marx, S, Penles, L. Health-related quality of life (HRQoL) among patients experiencing acute and chronic moderate-to-moderately-severe pain: results from a survey of 606 pain patients in the United States. Paper presented at: American Pain Society Annual Meeting; May 8-10, 2008; Tampa, Florida.
  5. MedicineNet.com Chronic Pain. Available at: http://www.medicinenet.com/chronic_pain/article.htm Accessed 5/2/2012.
  6. Lumley MA, Cohen JL, Borszcz GS, et al. Pain and emotion: a biopsychosocial review of recent research. J Clin Psychol. 2011;67(9):942-968.
  7. Coluzzi F, Berti M. Change Pain: changing the approach to chronic pain. Minerva Med. 2011;102(4):289-307.
  8. Woodcock J. A difficult balance--pain management, drug safety, and the FDA. N Engl J Med. 2009;361(22):2105-7.
  9. Peterson K, McDonagh M, Thakurta S, et al. Drug Class Review: Nonsteroidal Antiinflammatory Drugs (NSAIDs): Final Update 4 Report. National Institute of Health (NIH) PubMed Health. Bethesda (MD): National Library of Medicine (US).
  10. Smith HS. Pain Taxonomy. In: The Neurologic Basis for Pain, Pappagalo M (Ed), McGraw-Hill, New York 2005. p.289.
  11. NINDS (National Institute of Neurological Disorders and Stroke. Pain: Hope Through Research. Available at: http://www.ninds.nih.gov/disorders/chronic_pain/detail_chronic_pain.htm Accessed 5/4/2012.
  12. Cohen S., Raja S., Chapter 29 – Pain. In: Goldman: Goldman's Cecil Medicine, 24th ed. Pg 133. Copyright © 2011 Saunders, An Imprint of Elsevier. Philadelphia, PA.
  13. Costigan M, Scholz J, Woolf CJ. Neuropathic pain: a maladaptive response of the nervous system to damage. Annu Rev Neurosci. 2009;32:1-32.
  14. Vorobeychik Y, Gordin V, Mao J, Chen L. Combination therapy for neuropathic pain: a review of current evidence. CNS Drugs. 2011;25(12):1023-1034.
  15. Ji RR, Xu ZZ, Strichartz G, Serhan CN. Emerging roles of resolvins in the resolution of inflammation and pain. Trends Neurosci. 2011;34(11):599-609.
  16. Hassett AL, Williams DA. Non-pharmacological treatment of chronic widespread musculoskeletal pain. Best Pract Res Clin Rheumatol. 2011;25(2):299-309.
  17. Bajwa Z, Smith HS. Overview of the treatment of chronic pain. In: UpToDate, Aronson M. (Ed), Waltham, MA, 2012.
  18. Hersh EV, Pinto A, Moore PA. Adverse drug interactions involving common prescription and over-the-counter analgesic agents. Clin Ther. 2007;29(97):2477-97.
  19. Wilcox CM, Cryer B, Triadafilopoulos G. Patterns of use and public perception of over-the-counter pain relievers: focus on nonsteroidal antiinflammatory drugs. J Rheumatol. 2005;32(11):2218-24.
  20. Food and Drug Administration (FDA). Acetaminophen: background and overview. Meeting material from the June 29, 2009, joint meeting of the Drug Safety and Risk Management Advisory Committee with the Anesthetic and Life Support Advisory Committee and Nonprescription Drug Advisory Committee. Silver Spring, MD, 2009.
  21. Saccomano S, Deluca DA. Too toxic. Nurs Manage. 2008;39(9):32A-H.
  22. Weir MR. Renal effects of nonselective NSAIDs and coxibs. Cleve Clin J Med. 2002;69 Suppl 1:SI53-8.
  23. Ejaz P, Bhojani K, Joshi VR. NSAIDs and kidney. J Assoc Physicians India. 2004 Aug;52:632-40.
  24. National Institute of Health (NIH). Aspirin: AHFS Consumer Medication Information. PubMed Health [Internet]. Bethesda (MD): National Library of Medicine (US); [Last updated March 2011; Accessed April 2012]
  25. Von Korff M, Kolodny A, Deyo RA, Chou R. Long-term opioid therapy reconsidered. Ann Intern Med. 2011;155(5):325-328.
  26. Friedrich MJ. Research yields new insights into mechanisms and treatment of pain: JAMA. 2012 Jan 18;307(3):239-41.
  27. World Health Organization. Cancer pain releif. World Health Organization; Geneva, 1990.
  28. Chou R, Fanciullo GJ, Fine PG, et al. Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain. J Pain. 2009;10(2):113-130.
  29. Okie S. A flood of opioids, a rising tide of deaths. N Engl J Med. 2010;363(21):1981-1985.
  30. Edlund MJ, Steffick D, Hudson T, Harris KM, Sullivan M. Risk factors for clinically recognized opioid abuse and dependence among veterans using opioids for chronic non-cancer pain. Pain. 2007;129(3):355-362.
  31. Katz N, Mazer NA. The impact of opioids on the endocrine system. Clin J Pain. 2009;25(2):170-175.
  32. Aloisi AM, Aurilio C, Bachiocco V, et al. Endocrine consequences of opioid therapy. Psychoneuroendocrinology. 2009;34(1).
  33. Woodall WS. Opioids & the endocrine system. Adv NPs PAs. 2011;2(11):25-27.
  34. Vuong C, Van Uum SH, O'Dell LE, Lutfy K, Friedman TC. The effects of opioids and opioid analogs on animal and human endocrine systems. Endocr Rev. 2010;31(1):98-132.
  35. Merza Z. Chronic use of opioids and the endocrine system. Horm Metab Res. 2010;42(9):621-626.
  36. Aloisi A, Ceccarelli I, Carlucci M, et al. Hormone replacement therapy in morphine-induced hypogonadic male chronic pain patients. Reproductive Biology and Endocrinology. 2011;9(1):26.
  37. Mease PJ, Hanna S, Frakes EP, et al. Pain mechanisms in osteoarthritis: understanding the role of central pain and current approaches to its treatment. J Rheumatol. 2011 Aug;38(8):1546-51.
  38. Bradley LA, Kersh BC, DeBerry JJ, et al. Lessons from fibromyalgia: abnormal pain sensitivity in knee osteoarthritis. Novartis Found Symp. 2004;260:258-70; discussion 270-9.
  39. McCleane G. Antidepressants as Analgesics. CNS Drugs, Volume 22, Number 2, 2008 , pp. 139-156(18)
  40. Yalcin L, Choucair-Jaafar N, Benbouzid M, et al. beta(2)-adrenoceptors are critical for antidepressant treatment of neuropathic pain. Ann Neurol. 2009 Feb;65(2):218-25. Ann Neurol. 2009 Feb;65(2):218-25.
  41. Tennant F. A Diet for Patients With Chronic Pain. Practical Pain Management. 2011;11(6):1-2. Available at: http://www.practicalpainmanagement.com/treatments/complementary/diet-patients-chronic-pain
  42. Bell RF. Food and pain: Should we be more interested in what our patients eat? Pain. 2007;129(1-2):5-7.
  43. Ruskin DN, Kawamura M, Masino SA. Reduced pain and inflammation in juvenile and adult rats fed a ketogenic diet. PLoS One. 2009;4(12).
  44. Bonakdar R, Leopold D. Chapter 34: Integrative Medicine in Rheumatology: An Evidence-Based Approach. In: Firestein: Kelley's Textbook of Rheumatology, 8th ed. Philadelphia PA: Saunders Elsevier 2009.
  45. Tall JM, Raja SN. Dietary constituents as novel therapies for pain. Clin J Pain. 2004;20(1):19-26.
  46. Tokuyama S, Nakamoto K. Unsaturated fatty acids and pain. Biol Pharm Bull. 2011;34(8):1174-1178.
  47. Surette ME. The science behind dietary omega-3 fatty acids. Cmaj. 2008;178(2):177-180.
  48. Poff CD, Balazy M. Drugs that target lipoxygenases and leukotrienes as emerging therapies for asthma and cancer. Curr Drug Targets Inflamm Allergy. 2004 Mar;3(1):19-33.
  49. Bachi AL, Kim FJ, Nonogaki S, et al. Leukotriene B4 creates a favorable microenvironment for murine melanoma growth. Mol Cancer Res. 2009 Sep;7(9):1417-24.
  50. Larré S, Tran N, Fan C, et al. PGE2 and LTB4 tissue levels in benign and cancerous prostates. Prostaglandins Other Lipid Mediat. 2008 Dec;87(1-4):14-9.
  51. Sundaram S, Ghosh J. Expression of 5-oxoETE receptor in prostate cancer cells: critical role in survival. Biochem BiophysRes Commun. 2006 Jan 6;339(1):93-8.
  52. Zhi H, Zhang J, Hu G, et al. The deregulation of arachidonic acid metabolism-related genes in human esophageal squamous cell carcinoma. Int J Cancer. 2003 Sep 1;106(3):327-33.
  53. Penglis PS, Cleland LG, Demasi M, Caughey GE, James MJ. Differential regulation of prostaglandin E2 and thromboxane A2 production in human monocytes: implications for the use of cyclooxygenase inhibitors. J Immunol. 2000 Aug 1;165(3):1605-11.
  54. Rubinsztajn R, Wronska J, Chazan R. Urinary leukotriene E4 concentration in patients with bronchial asthma and intolerance of non-steroids anti-inflammatory drugs before and after oral aspirin challenge. Pol Arch Med Wewn. 2003 Aug;110(2):849-54.
  55. Subbarao K, Jala VR, Mathis S, et al. Role of leukotriene B4 receptors in the development of atherosclerosis: potential mechanisms. Arterioscler Thromb Vasc Biol. 2004 Feb;24(2):369-75.
  56. Laufer S. Role of eicosanoids in structural degradation in osteoarthritis. Curr Opin Rheumatol. 2003 Sep;15(5):623-7.
  57. Julémont F, Dogné, Pirotte B, et al. Recent development in the field of dual COX/5-LOS inhibitors. Mini Rev Med Chem. 2004;4(6):633-8.
  58. Nakahata N et al. Thromboxane A2: physiology/pathophysiology, cellular signal transduction and pharmacology. Pharmacol Ther. 2008 Apr;118(1):18-35.
  59. Suzuki J, Ogawa M, Watanabe R, et al, Roles of prostaglandin E2 in cardiovascular diseases. Int Heart J. 2011;52(5):266-9.
  60. Serhan CN. Novel eicosanoid and docosanoid mediators: resolvins, docosatrienes, and neuroprotectins. Curr Opin Clin Nutr Metab Care. 2005;8(2):115-121.
  61. Serhan C, Hong S, Gronert K, et al. A Family of Bioactive Products of Omega-3 Fatty Acid Transformation Circuits Initiated by Aspirin Treatment that Counter Proinflammation Signals October 21, 2002 // JEM vol. 196 no. 8 1025-1037
  62. Ko GD, Nowacki NB, Arseneau L, Eitel M, Hum A. Omega-3 fatty acids for neuropathic pain: case series. Clin J Pain. 2010;26(2):168-172.
  63. Kidd PM. Omega-3 DHA and EPA for cognition, behavior, and mood: clinical findings and structural-functional synergies with cell membrane phospholipids. Altern Med Rev. 2007;12(3):207-227.
  64. Manson JE. Pain: sex differences and implications for treatment. Metabolism. 2010;59(1):S16-20.
  65. Goldberg RJ, Katz J. A meta-analysis of the analgesic effects of omega-3 polyunsaturated fatty acid supplementation for inflammatory joint pain. Pain. 2007;129(1-2):210-223.
  66. Shapiro H. Could n-3 polyunsaturated fatty acids reduce pathological pain by direct actions on the nervous system? Prostaglandins Leukot Essent Fatty Acids. 2003;68(3):219-224.
  67. Johnson MM, Swan DD, Surette ME, et al. Dietary supplementation with gamma-linolenic acid alters fatty acid content and eicosanoid production in healthy humans. J Nutr. 1997 Aug;127(8):1435-44.
  68. Ziboh VA, Naguwa S, Vang K, et al. Suppression of leukotriene B4 generation by ex-vivo neutrophils isolated from asthma patients on dietary supplementation with gammalinolenic acid-containing borage oil: possible implication in asthma. Clin Dev Immunol. 2004 Mar;11(1):13-21.
  69. Chang CS, Sun HL, Lii CK, Chen HW, Chen PY, Liu KL. Gamma-linolenic acid inhibits inflammatory responses by regulating NF-kappaB and AP-1 activation in lipopolysaccharide-induced RAW 264.7 macrophages. Inflammation. 2010 Feb;33(1):46-57.
  70. Hontecillas R, O’Shea M, Einerhand A, Diguardo M, Bassaganya-Riera J. Activation of PPAR gamma and alpha by punicic acid ameliorates glucose tolerance and suppresses obesity-related inflammation. J Am Coll Nutr. 2009 Apr;28(2):184-95.
  71. Horrobin DF. The effects of gamma-linolenic acid on breast pain and diabetic neuropathy: possible non-eicosanoid mechanisms. Prostaglandins Leukot Essent Fatty Acids. 1993 Jan;48(1):101-4.
  72. Ranieri M, Sciuscio M, Cortese AM, et al. The use of alpha-lipoic acid (ALA), gamma linolenic acid (GLA) and rehabilitation in the treatment of back pain: effect on health-related quality of life. Int J Immunopathol Pharmacol. 2009 Jul-Sep;22(3 Suppl):45-50.
  73. Hansen TM, Lerche A, Kassis V, et al. Treatment of rheumatoid arthritis with prostaglandin E1 precursors cis-linoleic acid and gamma-linolenic acid. Scand J Rheumatol. 1983;12(2):85-8.
  74. Chaggar PS, Shaw SM, Williams SG. Review article: Thiazolidinediones and heart failure. Diab Vasc Dis Res. 2009 Jul;6(3):146-52.
  75. Proctor ML, Murphy PA. Herbal and dietary therapies for primary and secondary dysmenorrhoea. Cochrane Database Syst Rev. 2001;3.
  76. Koike H, Watanabe H, Inukai A, et al. Myopathy in thiamine deficiency: analysis of a case. J Neurol Sci. 2006;249(2):175-179.
  77. Ponce-Monter HA, Ortiz MI, Garza-Hernandez AF, et al. Effect of diclofenac with B vitamins on the treatment of acute pain originated by lower-limb fracture and surgery. Pain Res Treat. 2012;104782:31.
  78. Caram-Salas NL, Reyes-Garcia G, Medina-Santillan R, Granados-Soto V. Thiamine and cyanocobalamin relieve neuropathic pain in rats: synergy with dexamethasone. Pharmacology. 2006;77(2):53-62.
  79. Medina-Santillan R, Morales-Franco G, Espinoza-Raya J, Granados-Soto V, Reyes-Garcia G. Treatment of diabetic neuropathic pain with gabapentin alone or combined with vitamin B complex. preliminary results. Proc West Pharmacol Soc. 2004;47:109-112.
  80. Sanchez-Ramirez GM, Caram-Salas NL, Rocha-Gonzalez HI, et al. Benfotiamine relieves inflammatory and neuropathic pain in rats. Eur J Pharmacol. 2006;530(1-2):48-53.
  81. Mibielli MA, Geller M, Cohen JC, et al. Diclofenac plus B vitamins versus diclofenac monotherapy in lumbago: the DOLOR study. Curr Med Res Opin. 2009 Nov;25(11):2589-99.
  82. Lu R, Kallenborn-Gerhardt W, Geisslinger G, Schmidtko A. Additive antinociceptive effects of a combination of vitamin C and vitamin E after peripheral nerve injury. PLoS One. 2011;6(12):e29240. Epub 2011 Dec 14.
  83. Rosa KA, Gadotti VM, Rosa AO, Rodrigues AL, Calixto JB, Santos AR. Evidence for the involvement of glutamatergic system in the antinociceptive effect of ascorbic acid. Neurosci Lett. 2005;381(1-2):185-188.
  84. Chen JY, Chang CY, Feng PH, Chu CC, So EC, Hu ML. Plasma vitamin C is lower in postherpetic neuralgia patients and administration of vitamin C reduces spontaneous pain but not brush-evoked pain. Clin J Pain. 2009;25(7):562-569.
  85. Besse JL, Gadeyne S, Galand-Desme S, Lerat JL, Moyen B. Effect of vitamin C on prevention of complex regional pain syndrome type I in foot and ankle surgery. Foot Ankle Surg. 2009;15(4):179-182.
  86. Dusso AS, Brown AJ, Slatopolsky E. Vitamin D. American Journal of Physiology - Renal Physiology. July 1, 2005 2005;289(1):F8-F28.
  87. Gloth FM, 3rd, Greenough WB, 3rd. Vitamin D deficiency as a contributor to multiple forms of chronic pain: Mayo Clin Proc. 2004 May;79(5):696, 699; author reply 699.
  88. Lasco A, Catalano A, Benvenga S. Improvement of primary dysmenorrhea caused by a single oral dose of vitamin D: results of a randomized, double-blind, placebo-controlled study. Arch Intern Med. 2012 Feb 27;172(4):366-7.
  89. Selfridge NJ. Vitamin D and Pain: Making Sense of It All. Alternative Medicine Alert. 2010;13(7):77-78.
  90. Pruthi S, Wahner-Roedler DL, Torkelson CJ, et al. Vitamin E and evening primrose oil for management of cyclical mastalgia: a randomized pilot study. Altern Med Rev. 2010;15(1):59-67.
  91. Ziaei S, Zakeri M, Kazemnejad A. A randomised controlled trial of vitamin E in the treatment of primary dysmenorrhoea. Bjog. 2005;112(4):466-469.
  92. Kuhad A, Chopra K. Tocotrienol attenuates oxidative-nitrosative stress and inflammatory cascade in experimental model of diabetic neuropathy. Neuropharmacology. 2009;57(4):456-462.
  93. Tiwari V, Kuhad A, Chopra K. Tocotrienol ameliorates behavioral and biochemical alterations in the rat model of alcoholic neuropathy. Pain. 2009;145(1-2):129-135.
  94. Kim HK, Kim JH, Gao X, et al. Analgesic effect of vitamin E is mediated by reducing central sensitization in neuropathic pain. Pain. 2006a;122(1-2):53-62.
  95. Singh S. From Exotic Spice to Modern Drug? Cell. 2007;130(5):765-768.
  96. Cho JW, Lee KS, and Kim CW. rcumin attenuates the expression of IL-1beta, IL-6, and TNF-alpha as well as cyclin E in TNF-alpha-treated HaCaT cells; NF-kappaB and MAPKs as potential upstream targets. Int J Mol Med. 2007 Mar;19(3):469-74.
  97. Kim YS, Ahn Y, Hong MH, et al. Curcumin attenuates inflammatory responses of TNF-alpha-stimulated human endothelial cells. J Cardiovasc Pharmacol. 2007 Jul;50(1):41-9.
  98. Yeon KY, Kim SA, Kim YH, et al. Curcumin produces an antihyperalgesic effect via antagonism of TRPV1. J Dent Res. 2010;89(2):170-174.
  99. Agarwal KA, Tripathi CD, Agarwal BB, Saluja S. Efficacy of turmeric (curcumin) in pain and postoperative fatigue after laparoscopic cholecystectomy: a double-blind, randomized placebo-controlled study. Surg Endosc. 2011;25(12):3805-3810.
  100. Zheng J, Zheng C, Cao H, Li J, Lian Q. [Curcumin down-regulates CX3CR1 expression in spinal cord dorsal horn and DRG in neuropathic pain rats]. Zhongguo Zhong Yao Za Zhi. 2011;36(18):2552-2556.
  101. Black CD, Herring MP, Hurley DJ, O'Connor PJ. Ginger (Zingiber officinale) reduces muscle pain caused by eccentric exercise. J Pain. 2010;11(9):894-903.
  102. Khalid MH, Akhtar MN, Mohamad AS, et al. Antinociceptive effect of the essential oil of Zingiber zerumbet in mice: possible mechanisms. J Ethnopharmacol. 2011;137(1):345-351.
  103. Ozgoli G, Goli M, Moattar F. Comparison of effects of ginger, mefenamic acid, and ibuprofen on pain in women with primary dysmenorrhea. J Altern Complement Med. 2009;15(2):129-132.
  104. Ueda H, Ippoushi K, Takeuchi A. Repeated oral administration of the squeezed ginger (Zingiber officinale) extract augmented the serum corticosterone level and had anti-inflammatory properties. Biosci Biotechnol Biochem. 2010;74(11):2248-52.
  105. Banerjee B, Bagchi D. Beneficial effects of a novel IH636 grape seed proanthocyanidin extract in the treatment of chronic pancreatitis. Digestion. 2001;63(3):203-206.
  106. de la Iglesia R, Milagro FI, Campion J, Boque N, Martinez JA. Healthy properties of proanthocyanidins. Biofactors. 2010;36(3):159-168.
  107. DalBo S, Jurgensen S, Horst H, et al. Analysis of the antinociceptive effect of the proanthocyanidin-rich fraction obtained from Croton celtidifolius barks: evidence for a role of the dopaminergic system. Pharmacol Biochem Behav. 2006 Oct;85(2):317-23. Epub 2006 Oct 9.
  108. Kaur C. The pineal hormone melatonin in health and disease. Recent Pat Endocr Metab Immune Drug Discov. 2011;5(2):78-9.
  109. Wilhelmsen M, Amirian I, Reiter RJ, Rosenberg J, Gogenur I. Analgesic effects of melatonin: a review of current evidence from experimental and clinical studies. J Pineal Res. 2011;51(3):270-7.
  110. Gitto E, Aversa S, Salpietro CD, et al. Pain in neonatal intensive care: role of melatonin as an analgesic antioxidant. J Pineal Res. 2012 Apr;52(3):291-5.
  111. Srinivasan V, Pandi-Perumal SR, Spence DW, et al. Potential use of melatonergic drugs in analgesia: mechanisms of action. Brain Res Bull. 2010;81(4-5):362-71.
  112. Debbi EM, Agar G, Fichman G, et al. Efficacy of methylsulfonylmethane supplementation on osteoarthritis of the knee: a randomized controlled study. BMC Complement Altern Med. 2011;11:50.
  113. AMR (Alternative Medicine Review). Methylsulfonylmethane (MSM). Monograph. Altern Med Rev. 2003;8(4):438-41.
  114. Kim LS, Axelrod LJ, Howard P, Buratovich N, Waters RF. Efficacy of methylsulfonylmethane (MSM) in osteoarthritis pain of the knee: a pilot clinical trial. Osteoarthritis Cartilage. 2006;14(3):286-94.
  115. Notarnicola A, Tafuri S, Fusaro L, et al. The "MESACA" study: methylsulfonylmethane and boswellic acids in the treatment of gonarthrosis. Adv Ther. 2011 Oct;28(10):894-906. Epub 2011 Oct 7.
  116. Song JS, Chae J-W, Lee K-R, et al. Pharmacokinetic characterization of decursinol derived from Angelica gigas Nakai in rats. Xenobiotica. 2011;41(10):895-902.
  117. Kim KM, Kim MJ, Kang JS. Absorption, distribution, metabolism, and excretion of decursin and decursinol angelate from Angelica gigas Nakai. J Microbiol Biotechnol. 2009;19(12):1569-1572.
  118. Choi SS, Han KJ, Lee JK, et al. Antinociceptive mechanisms of orally administered decursinol in the mouse. Life Sci. 2003;73(4):471-485.
  119. Kim JH, Jeong JH, Jeon ST, et al. Decursin inhibits induction of inflammatory mediators by blocking nuclear factor-kappaB activation in macrophages. Mol Pharmacol. 2006b Jun;69(6):1783-90. Epub 2006 Mar 1.
  120. Seo YJ, Kwon MS, Park SH, et al. The analgesic effect of decursinol. Arch Pharm Res. 2009;32(6):937-943.
  121. Robb-Nicholson C. Ask the doctor. I have pain from osteoarthritis in both knees. I'm curious about the cream made from a substance in hot peppers. How does it relieve pain? Harv Womens Health Watch. 2011;19(2):8.
  122. Chrubasik S, Weiser T, Beime B. Effectiveness and safety of topical capsaicin cream in the treatment of chronic soft tissue pain. Phytother Res. 2010;24(12):1877-1885.
  123. England J, Wagner T, Kern KU, Roth-Daniek A, Sell A. The capsaicin 8% patch for peripheral neuropathic pain. Br J Nurs. 2011;20(15):926-931.
  124. Anand P, Bley K. Topical capsaicin for pain management: therapeutic potential and mechanisms of action of the new high-concentration capsaicin 8% patch. Br J Anaesth. 2011;107(4):490-502.
  125. Jones VM, Moore KA, Peterson DM. Capsaicin 8% topical patch (Qutenza)--a review of the evidence. J Pain Palliat Care Pharmacother. 2011;25(1):32-41.
  126. Fernstrom JD and Fernstrom MH. Tyrosine, phenylalanine, and catecholamine synthesis and function in the brain. J Nutr. 2007 Jun;137(6 Suppl 1):1539S-1547S; discussion 1548S.
  127. Kitade T, Odahara Y, Shinohara S, et al. Studies on the enhanced effect of acupuncture analgesia and acupuncture anesthesia by D-phenylalanine (2nd report)--schedule of administration and clinical effects in low back pain and tooth extraction. Acupunct Electrother Res. 1990;15(2):121-35.
  128. Donzelle G, Bernard L, Deumier R, et al. [Curing trial of complicated oncologic pain by D-phenylalanine (author's transl)]. Anesth Analg (Paris). 1981;38(11-12):655-8.
  129. Mitchell MJ, Daines GE, and Thomas BL. Effect of L-tryptophan and phenylalanine on burning pain threshold. Phys Ther. 1987 Feb;67(2):203-5.
  130. Walsh NE, Ramamurthy S, Schoenfeld L, et al. Analgesic effectiveness of D-phenylalanine in chronic pain patients. Arch Phys Med Rehabil. 1986 Jul;67(7):436-9.
  131. Dharmshaktu P, Tayal V, and Kalra BS. Efficacy of antidepressants as analgesics: a review. J Clin Pharmacol. 2012 Jan;52(1):6-17. Epub 2011 Mar 17.
  132. Amin B and Hosseinzadeh H. Evaluation of aqueous and ethanolic extracts of saffron, Crocus sativus L., and its constituents, safranal and crocin in allodynia and hyperalgesia induced by chronic constriction injury model of neuropathic pain in rats. Fitoterapia. 2012 Mar 28. [Epub ahead of print]
  133. Ceccherelli F, Diani MM, Altafini L. erative pain treated by intravenous L-tryptophan: a double-blind study versus placebo in cholecystectomized patients. Pain. 1991 Nov;47(2):163-72.
  134. Abenavoli L, Capasso R, Milic N, et al. Milk thistle in liver diseases: past, present, future. Phytother Res. 2010 Oct;24(10):1423-32.
  135. Bajt ML, Knight TR, Lemasters JJ et al. Acetaminophen-induced oxidant stress and cell injury in cultured mouse hepatocytes: protection by N-acetyl cysteine. Toxicol Sci. 2004 Aug;80(2):343-9. Epub 2004 Apr 28.